Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation

Clinical trial NCT07566585 · RECRUITING

Trial details

NCT number

NCT07566585

Sponsor

BlueSphere Bio, Inc

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2026-04-21

Primary completion

2027-08-01

Enrollment

19

View on ClinicalTrials.gov